Biomeme, Inc.
Biomeme, Inc. appears in FDA public data with 3 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (Z-0452-2022, Class II) was initiated on October 20, 2021.
Summary
- Total Recalls
- 3
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-0452-2022 | Class II | Biomeme SARS-CoV-2- Real Time RT-PCR Test, Instructions for Use, Part number 100002824 Subcomponent | October 20, 2021 |
| Z-0940-2021 | Class III | Nucleic acid-based in vitro diagnostic devices for the detection of 2019-novel coronavirus (2019-nCo | January 5, 2021 |
| Z-0513-2021 | Class II | The Biomeme SARS-CoV-2 Real-Time RT-PCR Test is a molecular in vitro diagnostic test that is based o | October 23, 2020 |